These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 38051903)

  • 1. Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson's disease: a systematic review and meta-analysis.
    Park JM; Rahmati M; Lee SC; Shin JI; Kim YW
    Neural Regen Res; 2024 Jul; 19(7):1584-1592. PubMed ID: 38051903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson's disease: a systematic review protocol.
    Karimi A; Elmi M; Shiri Z; Baharvand H
    Syst Rev; 2021 Jun; 10(1):188. PubMed ID: 34172098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease.
    Jiaming M; Niu C
    Neurol Sci; 2015 Feb; 36(2):281-7. PubMed ID: 25159816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis.
    Yang Z; Liang Z; Rao J; Lin F; Lin Y; Xu X; Wang C; Chen C
    Neural Regen Res; 2023 Nov; 18(11):2406-2412. PubMed ID: 37282470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease.
    Calice da Silva C; Azevedo BN; Machado DC; Zimmer ER; Martins LAM; da Costa JC
    Behav Brain Res; 2017 May; 324():30-40. PubMed ID: 28167338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
    Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
    Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell treatment for Parkinson's disease: an update for 2005.
    Snyder BJ; Olanow CW
    Curr Opin Neurol; 2005 Aug; 18(4):376-85. PubMed ID: 16003112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson's Disease.
    Hamedi H; Ghorbanian SH; Mirzaeian L; Abrari K; Mozdziak P; Ghorbanian MT
    Cell J; 2023 May; 25(5):317-326. PubMed ID: 37300293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.
    Xiong N; Yang H; Liu L; Xiong J; Zhang Z; Zhang X; Jia M; Huang J; Zhang Z; Mohamed AA; Lin Z; Wang T
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):411-422. PubMed ID: 23770451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
    Jiang Z; Wang J; Sun G; Feng M
    Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
    Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
    BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell therapy in Parkinson's disease animal models.
    Gugliandolo A; Bramanti P; Mazzon E
    Curr Res Transl Med; 2017; 65(2):51-60. PubMed ID: 28466824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.